Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Formulation strategies for a novel peptide-based HIV vaccine

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: DACOBA, Tamara (University of Santiago de Compostela, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Santiago de Compostela, Spain)
  • Co-author(s): Tamara G Dacoba: Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain;Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain;Department of Pharmacology, Pharmacy and Pharmaceutical Technology (School of Pharmacy), University of Santiago de Compostela, Santiago de Compostela, Spain
    Jose Crecente-Campo: Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain;Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain;Department of Pharmacology, Pharmacy and Pharmaceutical Technology (School of Pharmacy), University of Santiago de Compostela, Santiago de Compostela, Spain
    Jorge F Correia-Pinto: Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain;Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain;Department of Pharmacology, Pharmacy and Pharmaceutical Technology (School of Pharmacy), University of Santiago de Compostela, Santiago de Compostela, Spain
    Hongzhao Li: National Microbiology Laboratory, University of Manitoba, Winnipeg, Canada
    David Tang: National Microbiology Laboratory, University of Manitoba, Winnipeg, Canada
    Chris Czarnecki: National Microbiology Laboratory, University of Manitoba, Winnipeg, Canada
    Robert Omange: National Microbiology Laboratory, University of Manitoba, Winnipeg, Canada
    Ma Luo: National Microbiology Laboratory, University of Manitoba, Winnipeg, Canada
    Maria Jose Alonso: Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain;Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain;Department of Pharmacology, Pharmacy and Pharmaceutical Technology (School of Pharmacy), University of Santiago de Compostela, Santiago de Compostela, Spain
  • Abstract:

    Backgrounds

    Vaccinology is focusing on the use of peptide antigens containing only the epitopes responsible for the immune response. These antigens are poorly immunogenic, requiring the use of adjuvants to achieve the desirable immune protection. Currently, developing an efficient vaccine against HIV is a challenge, where many efforts have been

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses